title: Are morphologic and functional consequences of status epilepticus in infant rats progressive?
abstract: The present study examined whether status epilepticus (SE) induced by LiCl-pilocarpine in immature rats (postnatal day [P]12) interferes with normal development; leads to progressive epileptogenesis, or cognitive decline and to pathology similar to that seen in human temporal lobe epilepsy. We correlated the extent of pathologic changes with the severity of functional alterations or epilepsy. SE-induced changes were compared with those of rats with SE induced at P25. Animals of both ages were exposed to a battery of behavioral tests for up to 3months after SE. Rats with SE at P12 showed mild retardation of psychomotor development and delayed habituation, whereas rats with SE at P25 showed no habituation. Assessment in adulthood using the Morris water maze test revealed that SE at both P12 and P25 led to cognitive impairment and that the severity of the impairment increased with age. A handling test revealed increased aggression in rats with SE at P25, but not in rats with SE at P12. Epilepsy was diagnosed with continuous video-electroencephalographic (EEG) monitoring for up to 7d. P25 rats were monitored at 5months after SE and seizures were detected in 83.3% of animals. P12 animals were divided into two groups and monitored at 5 or 7months after SE. Both the severity and incidence of spontaneous recurrent seizures tended to progress with time, and their incidence increased from 50% to 87.5% at 5 and 7months, respectively. Morphometric analysis and stereologic assessment of hilar neurons performed after video-EEG monitoring revealed atrophy of temporal brain structures, enlargement of lateral ventricles, and loss of hilar neurons in both age groups. In P12 rats, morphologic damage also tended to progress over time. Performance of animals in the Morris water maze correlated with the severity of damage, but not with seizure parameters.
authors.affiliation: Institute of Physiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 4, Czech Republic. kubova@biomed.cas.cz
authors.forename: H
authors.initials: H
authors.lastname: Kubová
authors.forename: P
authors.initials: P
authors.lastname: Mareš
mesh_terms: D000374:Aggression / Q000523:psychology; D000375:Aging / Q000502:physiology; D000818:Animals; D000831:Animals, Newborn; D018692:Antimanic Agents; D001284:Atrophy; D001522:Behavior, Animal / Q000502:physiology; D001921:Brain / Q000473:pathology; D002552:Cerebral Ventricles / Q000473:pathology; D003072:Cognition Disorders / Q000209:etiology / Q000523:psychology; D018450:Disease Progression; D004569:Electroencephalography / Q000187:drug effects; D006624:Hippocampus / Q000473:pathology; D018021:Lithium Chloride; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D018721:Muscarinic Agonists; D010862:Pilocarpine; D011597:Psychomotor Performance / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D013226:Status Epilepticus / Q000139:chemically induced / Q000473:pathology* / Q000523:psychology*
chemical_list: D018692:Antimanic Agents; D018721:Muscarinic Agonists; D010862:Pilocarpine; D018021:Lithium Chloride